Cargando…

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Cardiovascular (CV) morbidity and mortality are a challenge in management of patients with systemic lupus erythematosus (SLE). Higher risk of CV disease in SLE patients is mostly related to accelerated atherosclerosis. Nevertheless, high prevalence of traditional cardiovascular risk factors in SLE p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Floris, Alberto, Piga, Matteo, Mangoni, Arduino Aleksander, Bortoluzzi, Alessandra, Erre, Gian Luca, Cauli, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835241/ https://www.ncbi.nlm.nih.gov/pubmed/29670462 http://dx.doi.org/10.1155/2018/3424136

Ejemplares similares

Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study
por: Floris, Alberto, et al.
Publicado: (2021)

Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis
por: Mangoni, Arduino A., et al.
Publicado: (2021)

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
por: Chessa, Elisabetta, et al.
Publicado: (2017)

Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
por: Mangoni, Arduino A., et al.
Publicado: (2017)

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
por: Erre, Gian Luca, et al.
Publicado: (2021)

A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis
por: Sotgia, Salvatore, et al.
Publicado: (2022)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
por: Piga, Matteo, et al.
Publicado: (2017)

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Cocco, Cristina, et al.
Publicado: (2023)

Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography
por: Piga, Matteo, et al.
Publicado: (2016)

Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis
por: Floris, Alberto, et al.
Publicado: (2021)

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
por: Mangoni, Arduino A, et al.
Publicado: (2018)

Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages
por: Mangoni, Arduino A., et al.
Publicado: (2021)

Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study
por: Bassu, Stefania, et al.
Publicado: (2020)

Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study
por: Floris, Alberto, et al.
Publicado: (2022)

Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus
por: Bortoluzzi, Alessandra, et al.
Publicado: (2018)

Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study
por: Erre, Gian Luca, et al.
Publicado: (2018)

AIF-1 gene does not confer susceptibility to Behçet’s disease: Analysis of extended haplotypes in Sardinian population
por: Angioni, Maria Maddalena, et al.
Publicado: (2018)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015)

Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2020)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Erre, Gian Luca, et al.
Publicado: (2019)

Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium
por: Ceccarelli, Fulvia, et al.
Publicado: (2022)

Polymyalgia rheumatica: an autoinflammatory disorder?
por: Floris, Alberto, et al.
Publicado: (2018)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
por: Piga, Matteo, et al.
Publicado: (2021)

Diagnostic accuracy of different blood cells-derived indexes in rheumatoid arthritis: A cross-sectional study
por: Erre, Gian Luca, et al.
Publicado: (2020)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Targeted Therapies in Axial Psoriatic Arthritis
por: Floris, Alberto, et al.
Publicado: (2021)

Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
por: Erre, Gian Luca, et al.
Publicado: (2021)

Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review
por: Chessa, Elisabetta, et al.
Publicado: (2021)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2022)

Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
por: Hidekawa, Chiharu, et al.
Publicado: (2023)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
por: Olsen, Nancy J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1uu5u9tvg9r4kiga8cohevj315